Document is current
Any future updates will be listed below
-
Authors
Srifa, Waracharee https://orcid.org/0000-0002-6821-2451
Kosaric, Nina
Amorin, Alvaro https://orcid.org/0000-0002-3500-5085
Jadi, Othmane https://orcid.org/0000-0002-2675-1916
Park, Yujin
Mantri, Sruthi
Camarena, Joab https://orcid.org/0000-0002-3102-5820
Gurtner, Geoffrey C.
Porteus, Matthew https://orcid.org/0000-0002-3850-4648
-
Funding
Funding for this research was provided by:
Chan Zuckerberg Biohub, Amon Carter Foundation
- License Information
-
More Information
Article History
Received: 29 July 2019
Accepted: 25 February 2020
First Online: 18 May 2020
Competing interests
: M.P. serves on the SAB and has equity in CRISPR Tx and Allogene Tx. Neither company had input into the work described in the manuscript. All other authors declare no competing interests.
